Potential biomarkers for the diagnosis of respiratory tract infection and lungs cancer.

Potential biomarkers for the diagnosis of respiratory tract infection and lungs cancer. Cell Mol Biol (Noisy-le-grand). 2017 Nov 30;63(11):46-52 Authors: Khan K, Aslam MA, Zahra FT, Basheer H, Bilal M, Sumrin A Abstract Major hurdle faced by many physicians in treating various respiratory tract infections and lung carcinomas is their late or mis-diagnosis. In most respiratory tract infections the manner of infection is not completely understood. Similarly, various lung carcinomas are diagnosed at advance stages at which not only the treatment possibilities are narrowed but the chances of survival are also reduced. So, for the sake of better treatment, the quick and improved diagnostic strategies are suggested. Protein biomarkers fully fit the description in this regard as they have shown great potential in specific diagnosis of many respiratory diseases and also have shown capability in timely pin pointing different stages of lung carcinomas. Many serum biomarkers are presently being used for diagnosis but the efficiency for diagnosis of these biomarkers is lower when used alone. So, physicians are suggested to use the combination of different biomarkers. Moreover, genetic biomarkers are also currently studied to indicate the exact stage of disease, the possible damage occurred, the severity of disease and also for the analysis of the possible body response to the therapeutics. PMID: 29208181 [PubMed - in process]
Source: Cellular and Molecular Biology - Category: Molecular Biology Tags: Cell Mol Biol (Noisy-le-grand) Source Type: research

Related Links:

AbstractBladder cancer is the fourth most common cancer in men and fifth most common overall. The use of next-generation sequencing (NGS) approaches is crucial to precisely characterize the molecular defects of tumors, and this information could be combined with other clinical data, such as tumor histology and TNM staging, with the goal of precise tumor classification. In many settings, targeted NGS is evaluated in patients with first- and second-line metastatic cancer. Yet, in the decade to come we anticipate increased application of precision oncology at all stages of bladder cancer with the aim of customizing cancer tre...
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
Authors: Xiong Y, Zhao Q, Gu L, Liu C, Wang C Abstract The goal of this evaluation was to examine the mechanisms of Shenqi Fuzheng injection (SFI), an extract made from the plants Radix Astragali and Radix Codonopsis, in the process of chemotherapy sensitivity in non-small-cell lung cancer (NSCLC) cells. We investigated the expression of mitofusin-2 (Mfn2), a mitochondrial GTPase that may be related to chemoresistance, and found that Mfn2 expression was lower in human cisplatin-resistant lung carcinoma A549/DDP cells than in cisplatin-susceptible A549 cells. Chemosensitivity to cisplatin was restored in A549/DDP ce...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Publication date: Available online 7 November 2018Source: Materials Science and Engineering: CAuthor(s): María J. Limeres, Marcela A. Moretton, Ezequiel Bernabeu, Diego A. Chiappetta, María L. CuestasAbstractNanotechnology has recently emerged as a promising tool in biomedicine research. An important branch of nanotechnology is drug delivery and drug targeting using a wide range of biomaterials with promising potential applications in cancer research. The aim of this review is to provide an overview of the evolution of nanotechnology in cancer therapy, exemplified by a myriad of applications in drug delivery,...
Source: Materials Science and Engineering: C - Category: Materials Science Source Type: research
Publication date: Available online 9 November 2018Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseaseAuthor(s): Florian Kleinegger, Eva Hofer, Christina Wodlej, Nicole Golob-Schwarzl, Anna Maria Birkl-Toeglhofer, Alexander Stallinger, Johannes Petzold, Anna Orlova, Stefanie Krassnig, Robert Reihs, Tobias Niedrist, Harald Mangge, Young Nyun Park, Michael Thalhammer, Ariane Aigelsreiter, Sigurd Lax, Christoph Garbers, Peter Fickert, Stefan Rose-John, Richard MorigglAbstractBiliary tract cancer (BTC) represents a malignant tumor of the biliary tract including cholangiocarcinoma (CCA) and the carcinoma of ...
Source: Biochimica et Biophysica Acta (BBA) Molecular Basis of Disease - Category: Molecular Biology Source Type: research
Publication date: Available online 10 November 2018Source: European UrologyAuthor(s): Steven C. Campbell, Chalairat Suk-Ouichai, Yun-Lin Ye
Source: European Urology - Category: Urology & Nephrology Source Type: research
Publication date: Available online 10 November 2018Source: Pathology - Research and PracticeAuthor(s): Jiayin Hou, Huayu Wu, Rongquan He, Peng Lin, Yiwu Dang, Gang ChenAbstractLiver cancer is one of the few tumors with a steadily increasing morbidity and mortality; hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. We combined the expression profiles of Chaperonin Containing T-complex 1 Subunit 3 (CCT3) in HCC tissues based on microarray and RNA-sequencing data. The CCT3 expression levels were extracted and examined based on 421 samples from The Cancer Genome Atlas (TCGA) (HCC, n =&thins...
Source: Pathology Research and Practice - Category: Pathology Source Type: research
Publication date: Available online 10 November 2018Source: Pathology - Research and PracticeAuthor(s): Xin-gan Qin, Jiang-hui Zeng, Peng Lin, Wei-jia Mo, Qing Li, Zhen-bo Feng, Dian-zhong Luo, Hong Yang, Gang Chen, Jing-jing ZengAbstractMalignant tumors of the digestive tract include esophageal, gastric, and colorectal carcinomas, which all have high global mortality rates. A clinical role for small nuclear RNA (snRNA), a type of small non-coding RNA, has not yet been documented for digestive tract pan-adenocarcinomas. Therefore, the aim of the study was to identify differentially expressed snRNAs and to explore their prog...
Source: Pathology Research and Practice - Category: Pathology Source Type: research
This study assessed a national healthcare intervention launched in Sweden in 2015 to reduce the time between macroscopic haematuria, diagnosis and treatment of urinary tract cancer. METHODS: The outcome of the first 11 months was evaluated in 1697 individuals referred to a standardized care pathway for urinary tract cancer compared with 174 patients with conventionally diagnosed urothelial carcinoma. RESULTS: Among the referred individuals, 317 (19%) were diagnosed with cancer, 1034 (61%) had a benign diagnosis and 345 (20%) had a negative evaluation. Bladder cancer was the most common malignant diagnosis [262/317 ...
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Tags: Scand J Urol Source Type: research
In conclusion, lncRNAs can serve as potential diagnostic biomarkers of HCC with high sensitivity and specificity. In addition, lncRNAs panel from serum and plasma has a relatively high diagnostic value for HCC patients from Asia. PMID: 30410873 [PubMed - in process]
Source: Canadian Journal of Gastroenterology - Category: Gastroenterology Tags: Can J Gastroenterol Hepatol Source Type: research
Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-κB pathway. Oncotarget. 2018 Oct 05;9(78):34838-34854 Authors: Momen-Heravi F, Bala S Abstract Extracellular vesicles (EVs) are carriers of different biomacromolecules that participate in cellular signaling and disease pathogenesis. Although it has been shown that EVs can play an active role in cellular communication and different stages of cancer progression, the role of EVs in oral squamous cell carcinoma (OSCC) cancer pathogenesis, especially in the crosstalk of cancer cells with immu...
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Carcinoma | Genetics | Molecular Biology | Respiratory Medicine